US Patent Issued to Principia Biopharma on July 7 for "Process for preparing an amorphous form of 2-[3-[4-amino-3-(2-fluoro-4-phenoxyphenyl)pyrazolo[3,4-dpyrimidin-1-ylpiperidine-1-carbonyl-4-methyl-4-[4-(oxetan-3-yl)piperazin-1-ylpent-2-enenitrile" (California, Massachusetts Inventors)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,953, issued on July 7, was assigned to Principia Biopharma Inc. (Morristown, N.J.).

"Process for preparing an amorphous form of 2-[3-[4-amino-3-(2-fluoro-4-phenoxyphenyl)pyrazolo[3,4-dpyrimidin-1-ylpiperidine-1-carbonyl-4-methyl-4-[4-(oxetan-3-yl)piperazin-1-ylpent-2-enenitrile" was invented by Kolbot By (San Ramon, Calif.), Katherine Chu (Cambridge, Mass.), Mohammad R. Masjedizadeh (San Jose, Calif.), Pasit Phiasivongsa (Hillsborough, Calif.) and Jiang Zhu (San Ramon, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Solid forms of Compound (I):are disclosed. Pharmaceutical compositions comprising the same, methods of treating disorders and cond...